📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. (2021)

First Author: Rajoli RKR

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14619

PubMed Identifier: 33085781

Publication URI: http://europepmc.org/abstract/MED/33085781

Type: Journal Article/Review

Volume: 87

Parent Publication: British journal of clinical pharmacology

Issue: 4

ISSN: 0306-5251